Which named medical facilities yield superior results for radical prostatectomy and prostate cancer treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

High-Volume Centers Provide Superior Radical Prostatectomy Outcomes

Patients should undergo radical prostatectomy at high-volume centers with high-volume surgeons, as these facilities consistently demonstrate superior oncological and perioperative outcomes compared to low-volume centers. 1

The Volume-Outcome Relationship

The evidence unequivocally demonstrates that surgical volume matters significantly for radical prostatectomy outcomes. High-volume surgeons operating in high-volume centers generally provide superior outcomes across multiple metrics including cancer control, complication rates, and functional results 1.

What Defines a High-Volume Center

While the guidelines don't specify exact numerical thresholds for "high-volume," the evidence shows:

  • Centralization is occurring: Between 2000-2008, radical prostatectomy volume increased 74% while the number of hospitals performing the procedure decreased 19%, resulting in concentration at select facilities 2
  • Top-quartile volume hospitals are absorbing the majority of increased case volume 2
  • Teaching hospitals, urban locations, and large bed-size facilities are associated with higher volumes and better outcomes 3, 2

Specific Outcome Advantages at High-Volume Centers

Perioperative outcomes:

  • Significantly lower prolonged hospitalization rates (5.4% vs 19.0% at low-volume centers; unadjusted OR 4.2) 3
  • 45% lower total complication rate (OR 0.55) 4
  • Shorter length of stay and fewer surgical complications 1
  • Lower rates of blood transfusions 1

Oncological outcomes:

  • Better long-term cancer control 1
  • More appropriate patient selection for nerve-sparing approaches 1
  • Lower positive surgical margin rates in experienced hands 1

Certified Prostate Cancer Centers

Certified prostate cancer centers demonstrate measurably improved outcomes compared to the pre-certification era and non-certified facilities 5. German data from certified centers showed:

  • Significantly lower complication rates
  • Reduced reintervention rates
  • Fewer transfusions
  • Lower R1 (positive margin) status rates 5

However, the IMPROVE study found that while certified centers had 45% lower total complication rates, similarly favorable outcomes were achieved in both certified and non-certified centers within their study group, though this cannot be generalized to the broader treatment landscape 4.

The Robotic Surgery Factor

Hospitals with robotic technology demonstrate higher volumes and potentially better functional outcomes 2, 4. Key findings:

  • Robotic-assisted prostatectomy is significantly more common at high-volume centers (68.3% vs 18% at non-certified centers) 4
  • Patients treated with robotic-assisted RP reported significantly less stress urinary incontinence (OR 0.39) and decision regret (OR 0.62) 4
  • Robotic approach shows advantages in 12-month urinary continence and potency recovery compared to open approaches 1

Practical Implications

When selecting a facility, prioritize:

  1. Hospital characteristics: Teaching hospitals, urban locations, large bed size 3, 2
  2. Technology investment: Facilities with robotic surgical systems 2, 4
  3. Certification status: Certified prostate cancer centers when available 5
  4. Surgeon experience: High-volume surgeons within high-volume centers 1

Important Caveats

  • The volume effect persists even after adjusting for differences in available health services (14.8% attenuation) 3
  • High-volume hospitals offer a wider array of specialized medical and ancillary services specific to post-prostatectomy care 3
  • Learning curves for robotic prostatectomy extend beyond 300 cases for optimal functional outcomes and positive margin rates 6

The evidence does not identify specific named medical facilities, but rather establishes clear institutional characteristics associated with superior outcomes. Patients should seek facilities meeting the high-volume, teaching hospital, urban, large bed-size, and robotic-equipped criteria described above.

Related Questions

In a 76-year-old patient with a history of prostate cancer who presented after a syncopal episode and whose head and neck computed tomography angiography shows stenosis of the anterior cerebral artery (ACA), posterior cerebral artery (PCA), and middle cerebral artery (MCA) M2 branch with bilateral putamen infarcts, what is the next step in management?
In an 80-year-old man who had a partial transurethral resection of the prostate (TURP), when can radiation therapy for prostate cancer be initiated?
What antidepressant is recommended for a patient who has completed prostate cancer treatment and is experiencing sexual side effects, excluding mirtazapine and bupropion?
Are prostate cancers typically round in shape?
What is the recommended management for a patient with Gleason 3 + 4 (score 7) prostate cancer and a PSA of 4 ng/mL?
What is the recommended pediatric dose of Maltofer oral syrup (iron polymaltose complex) for children?
In a 35-year-old male with a left-sided peritonsillar abscess measuring about 2 cm and presenting with dysphagia, what is the appropriate intravenous antibiotic regimen?
What is the percentage increase in plasma MDMA concentration when co-administered with bupropion?
How should a diazepam overdose be managed?
In a patient with a history of obstructive sleep apnea who used CPAP the day before a home sleep study that showed nocturnal desaturation without obstructive events, what is the recommended next evaluation and management?
Are there any interactions between MDMA (3,4‑methylenedioxymethamphetamine) and propranolol, Adderall (amphetamine/dextroamphetamine), acyclovir, rosuvastatin (Crestor), ibuprofen, or acetaminophen (Tylenol)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.